Overview

A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Clarithromycin Extended Release for the Treatment of Pneumonia in Adult Patients

Status:
Completed

Trial end date:
2004-03-01

Target enrollment:

Participant gender:

Summary

The study was performed to confirm that a single, 2.0 g oral dose of azithromycin sustained release (SR) at least as effective as 7 days of clarithromycin extended release (ER), 1.0 g by mouth once daily, when used to treat adults with mild to moderate community acquired pneumonia (CAP), and that both treatments were safe.

Phase:

Phase 3

Details

Lead Sponsor:

Pfizer

Treatments:

Azithromycin
Clarithromycin